abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Sepsis
Interventions
DIAGNOSTIC_TEST

abioSCOPE

The abioSCOPE device with the PSP assay is intended to be indicated for ICU admitted patients at risk of developing sepsis. Results of abioSCOPE PSP assay may aid to identify sepsis in critically ill patients, together with all other clinical assessment and laboratory findings.

Trial Locations (1)

63141

Sundance Clinical, St Louis

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Avania

INDUSTRY

lead

Abionic SA

INDUSTRY

NCT05849935 - abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003 | Biotech Hunter | Biotech Hunter